ANVISA registration

COVI-Pro Autoteste rápido de antígeno COVID-19

Registration 81203440014. AUTOTESTE PARA ANTÍGENO DO SARS-COV-2 (CORONAVÍRUS)

Registration details

Registration number81203440014
Application number25351265920202236
Technical nameAUTOTESTE PARA ANTÍGENO DO SARS-COV-2 (CORONAVÍRUS)
Risk classIII
Published on17/04/2023
ValidityValid until 17/04/2033

Registration holder

Legal nameBIOTECH LOGÍSTICA LTDA- EPP
CNPJ21.382.943/0001-04

Manufacturer

  • INNOVA MEDICAL GROUP, INC. ESTADOS UNIDOS DA AMÉRICA

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist